NCI Cancer Bulletin: A Trusted Source for Cancer Research News
NCI Cancer Bulletin: A Trusted Source for Cancer Research News
January 11, 2005 • Volume 2 / Number 2 E-Mail This Document  |  View PDF Version  |  Bulletin Archive/Search  |  Subscribe

Bulletin Home

Featured Article
New Study Reveals Genotype that Causes SSRI Interference with Tamoxifen

Director's Update
NCI Leadership: A Model for Success

Spotlight
Targeting Mesothelin Shows Promise for Mesothelioma, Pancreatic, and Ovarian Cancers

Cancer Research Highlights
International Mammography Performance Compared

Bcl-2 Expression Suppresses DNA Mismatch Repair

Gefitinib Fails to Show Survival Benefit

CEA-TRICOM Vaccine Proves Safe and Effective in Phase I Trial

Funding Opportunities

Featured Clinical Trial
Hormone Therapy Plus Chemotherapy For Prostate Cancer

Notes
Clinic Receives Media Award

Comments Invited on Future Biospecimen Needs

Last Chance for Web Site Input on Future of Clinical Trials

Imaging Informatics Resource Launched

Coffey Discusses Common Denominators of Cancer

Community Update
"TEAM-UP" for Cervical Cancer Screening Month

Bulletin Archive

Page Options
Print This Page  Print This Page
Print This Document  Print This Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
View/Print PDF  View/Print PDF
Funding Opportunities

For comprehensive information about NCI funding priorities and opportunities, go to http://www.cancer.gov/researchandfunding.

The NIH Roadmap for Medical Research Funding provides a framework of the priorities NIH must address to optimize its research portfolio. It identifies the most compelling opportunities in three main areas: new pathways to discovery, research teams of the future, and re-engineering the clinical research enterprise. For complete information on Roadmap funding opportunities, go to http://nihroadmap.nih.gov. Newly released Roadmap funding opportunities are listed below.

Interdisciplinary Training: Behavior, Environment and Biology
RFA-RM-05-010
This postdoctoral, institutional National Research Service Award (NRSA) will support the establishment of innovative programs that provide formal coursework and research training in a new interdisciplinary field to individuals holding advanced degrees in a different discipline. This RFA will use the Ruth L. Kirschstein NRSA institutional research training grant (T32) mechanism.

For the complete RFA, go to http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-05-010.html. More information is available at http://nihroadmap.nih.gov/interdisciplinary/index.asp.

Molecular Libraries Screening Instrumentation - SBIR/STTR
PA-05-014
This PA invites research applications to develop innovative instrumentation to maximize the efficiency and augment the capabilities of molecular library high-throughput screening systems. This PA will use the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) mechanisms, and accompanies a Request for Applications of similar scientific intent (RFA RM-04-020) that will use the traditional research project grant (R01) mechanism.

For the complete PA, go to http://grants.nih.gov/grants/guide/pa-files/PA-05-014.html. More information is available at http://nihroadmap.nih.gov/molecularlibraries/index.asp.

Pilot-Scale Libraries for High-Throughput Screening
RFA-RM-05-014
This RFA invites applications for funding from the NIH Molecular Libraries Roadmap program for the generation of pilot-scale chemical diversity libraries. These libraries will be used for high-throughput biological screening by the Molecular Libraries Screening Center Network (MLSCN). The NIH Biotechnology Resource Grant (P41) award mechanism will be used. This is a one-time solicitation for 3-year grants. Letters of Intent are due January 14, 2005.

For the complete RFA, go to http://grants1.nih.gov/grants/guide/rfa-files/RFA-RM-05-014.html. More information is available at http://nihroadmap.nih.gov/molecularlibraries/index.asp.

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov